SleepCogni is a British award-winning first-in-class medical device for the diagnosis and treatment of sleep disorders. SleepCogni’s patented bedside and wearable device system helps sleep professionals better understand insomniacs and offers a range of proven interventions, such as CBT-I. We offer a comprehensive digital and technological solution integrating information on physiology, behaviour and the sleeping environment. We are funded by one of the UK's leading venture capital funds, Mercia Technologies Plc and more recently by the UK’s governmental Innovation agency, InnovateUK. We are working with some of the worlds'​ leading technologists, sleep clinicians and universities. Currently, we are moving from our research & development phase towards clinically validating our device’s measurements, before moving onto clinical trials in 2018.